In today’s world, cancer is no longer treated with a one-size-fits-all approach. With medical science advancing rapidly, cancer treatment has become more focused, less harmful, and far more effective thanks to a new approach called Precision Oncology.

‘Not all cancers behave the same, even if they are of the same type,’ says Dr. Nikhil Suresh Ghadyalpatil, Director and Consultant Medical Oncologist at Apollo Cancer Centre. ‘Through advanced testing, we can now understand the specific genetic makeup of a tumour, allowing us to choose the treatment that works best for that individual.’

Cancer is complex. Two people with the same diagnosis may respond very differently to the same treatment. Precision Oncology uses genomic testing and biomarkers to identify what’s driving a patient’s tumour and targets it directly. This approach improves treatment outcomes and reduces side effects, making life easier for the patient during and after therapy.

A key pillar of Apollo Cancer Centre’s success is its Multidisciplinary Tumour Board. This group includes not just oncologists, radiologists, and pathologists but also organ-specific cancer experts, such as uro-oncologists, gynae-oncologists, breast cancer specialists, bone tumour surgeons, GI cancer experts, and head and neck cancer surgeons. Together, they review each patient’s case and design a customized treatment plan, ensuring no detail is overlooked.

Apollo Cancer Centre offers some of the most cutting-edge technologies and therapies, including Immunotherapy and CAR T-cell therapy, Antibody-drug conjugates and PRRT, Robotic surgeries for better precision and recovery and Organ-preserving surgeries, such as breast conservation, limb salvage, and sphincter-sparing techniques. These options not only increase survival rates but also help patients return to normal life faster and with fewer long-term side effects.

— Dr Nikhil Suresh Ghadyalpatil Director - Medical Oncology Apollo Cancer Centres